Femasys (FEMY) Competitors

Sight Sciences (NASDAQ:SGHT) and Femasys (NASDAQ:FEMY) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, media sentiment, profitability, community ranking, dividends, analyst recommendations, institutional ownership, earnings and risk.

Does the MarketBeat Community prefer SGHT or FEMY?

Femasys received 15 more outperform votes than Sight Sciences when rated by MarketBeat users. Likewise, 74.47% of users gave Femasys an outperform vote while only 30.30% of users gave Sight Sciences an outperform vote.

Company	Underperform	Outperform
Sight Sciences	Outperform Votes 20 30.30%	Underperform Votes 46 69.70%
Femasys	Outperform Votes 35 74.47%	Underperform Votes 12 25.53%

Do analysts prefer SGHT or FEMY?

Sight Sciences currently has a consensus target price of $3.83, suggesting a potential upside of 42.50%. Femasys has a consensus target price of $11.50, suggesting a potential upside of 618.75%. Given Femasys' stronger consensus rating and higher possible upside, analysts clearly believe Femasys is more favorable than Sight Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sight Sciences	0 Sell rating(s)	5 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.29
Femasys	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media prefer SGHT or FEMY?

In the previous week, Femasys had 9 more articles in the media than Sight Sciences. MarketBeat recorded 11 mentions for Femasys and 2 mentions for Sight Sciences. Sight Sciences' average media sentiment score of 0.74 beat Femasys' score of -0.03 indicating that Sight Sciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sight Sciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Femasys	0 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has more risk and volatility, SGHT or FEMY?

Sight Sciences has a beta of 2.52, suggesting that its share price is 152% more volatile than the S&P 500. Comparatively, Femasys has a beta of -2.85, suggesting that its share price is 385% less volatile than the S&P 500.

Do institutionals & insiders believe in SGHT or FEMY?

55.5% of Sight Sciences shares are held by institutional investors. Comparatively, 65.3% of Femasys shares are held by institutional investors. 28.9% of Sight Sciences shares are held by company insiders. Comparatively, 12.3% of Femasys shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Is SGHT or FEMY more profitable?

Sight Sciences has a net margin of -63.30% compared to Femasys' net margin of -1,435.77%. Sight Sciences' return on equity of -47.28% beat Femasys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sight Sciences	-63.30%	-47.28%	-32.72%
Femasys	-1,435.77%	-141.49%	-82.30%

Which has stronger valuation & earnings, SGHT or FEMY?

Femasys has lower revenue, but higher earnings than Sight Sciences. Sight Sciences is trading at a lower price-to-earnings ratio than Femasys, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sight Sciences	$79.87M	1.73	-$55.55M	-$1.03	-2.61
Femasys	$1.26M	29.06	-$14.25M	-$0.81	-1.98

Summary

Femasys beats Sight Sciences on 10 of the 17 factors compared between the two stocks.